Cu2O@CaCO3 nanocomposites inhibited CRC distant metastasis and recurrence by immunotherapy through inducing an immunologically favorable TME and intensing the immune responses of anti-CD47 antibodies (66). The gene discussed is CD47; the disease is colorectal carcinoma.